Description
Tulobuterolisalong-actingβ2-adrenergicreceptoragoNISTthatisclinicallyusedinsomecountriestotreatchronicobstructivepulmonarydisorder(COPD)andasthma.Tulobuterolexhibitsbronchodilatory,anti-inflammatory,andantiviralactivities.Tulobuteroltreatspulmonarydisordersbyinducingrelaxationofairwaysmoothmusclecells.Intrachealepithelialcells,tulobuterolalsopreventsactivationofNF-κBanddecreaseslevelsofICAM-1,IL-1β,IL-6,andIL-8,inhibitingrhinovirusreplication.
References
YamayaM,NishimuraH,NADIneL,etal.Tulobuterolinhibitsrhinovirusinfectioninprimaryculturesofhumantrachealepithelialcells.PhysiolRep.2013Aug;1(3):e00041.PMID:24303127.
KatsunumaT,FujisawaT,NagaoM,etal.Effectsoftransdermaltulobuterolinpediatricasthmapatientsonlong-termleukotrienereceptorantagonisttherapy:resultsofarandomized,open-label,multicenterclinicaltrialinJapanesechildrenaged4-12years.AllergolInt.2013Mar;62(1):37-43.PMID:23000726.
TerpstraGK,RaaijmakersJA.Beta-agonisticpropertiesoftulobuterol,anewbeta-sympathicomimeticdrug,anditseffectsonpulmonarybeta-adrenoceptorcharacteristics.Lung.1990;168Suppl:179-85.PMID:1974673.
RuffF,ZanderJF,EdouteY,etal.Beta-2adrenergicresponsestotulobuterolinairwaysmoothmuscle,vascularsmoothmuscleandadrenergicnerves.JPharmacolExpTher.1988Jan;244(1):173-80.PMID:2826765.